Area of Science:

• Microbiology
• Clinical Diagnostics
• Molecular Biology

Background:

• Tuberculosis (TB) diagnosis relies on various methods, with Polymerase Chain Reaction (PCR) offering rapid detection.
• Current PCR assays, like Cobas TaqMan MTB, are primarily validated for respiratory specimens.
• Inappropriate requests for non-respiratory samples and limitations in smear-negative cases impact diagnostic accuracy and resource allocation.

Purpose of the Study:

• To evaluate the performance of PCR assays for tuberculosis detection across different specimen types.
• To assess the clinical utility and limitations of PCR in diagnosing TB, monitoring treatment, and screening patients.
• To analyze the cost-effectiveness and diagnostic yield of PCR testing in routine clinical practice.

Main Methods:

• Performance analysis of PCR assays (e.g., Cobas TaqMan MTB) using respiratory and non-respiratory specimens.
• Comparative evaluation of PCR sensitivity and specificity against smear microscopy and other diagnostic standards.
• Assessment of PCR utility for treatment monitoring, relapse detection, and patient screening.

Main Results:

• PCR assays demonstrate high performance in smear-positive respiratory samples.
• Sensitivity is significantly lower in smear-negative respiratory and all non-respiratory samples.
• High specificity allows differentiation between TB and environmental mycobacteria, but PCR is unsuitable for treatment evaluation, relapse detection, screening, or assessing contagiousness.

Conclusions:

• PCR is a valuable tool for rapid TB detection in smear-positive respiratory samples.
• Current PCR assays have limitations in sensitivity for smear-negative and non-respiratory specimens.
• PCR should not be used for treatment monitoring, relapse exclusion, screening, or evaluating contagiousness due to insufficient evidence and potential for misdiagnosis.